Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Mar 10, 2022	Report of unscheduled material events or corporate event	8-K	View HTML 0001867096-22-000033.pdf 0001867096-22-000033.rtf 0001867096-22-000033.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 24, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001867096-22-000025.pdf 0001867096-22-000025.rtf 0001867096-22-000025.xls
Feb 14, 2022	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001398344-22-003371.pdf 0001398344-22-003371.rtf 0001398344-22-003371.xls
Feb 11, 2022	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001193805-22-000261.pdf 0001193805-22-000261.rtf 0001193805-22-000261.xls
Feb 08, 2022	Form of prospectus reflecting facts events constituting substantive change from last form	424B3	View HTML 0001628280-22-001944.pdf 0001628280-22-001944.rtf 0001628280-22-001944.xls
Feb 07, 2022	EFFECT	EFFECT	View HTML 9999999995-22-000355.pdf 9999999995-22-000355.rtf 9999999995-22-000355.xls
Feb 07, 2022	EFFECT	EFFECT	View HTML 9999999995-22-000356.pdf 9999999995-22-000356.rtf 9999999995-22-000356.xls
Feb 04, 2022	CORRESP	CORRESP	View HTML 0001628280-22-001856.pdf 0001628280-22-001856.rtf 0001628280-22-001856.xls
Feb 04, 2022	CORRESP	CORRESP	View HTML 0001628280-22-001855.pdf 0001628280-22-001855.rtf 0001628280-22-001855.xls
Feb 01, 2022	UPLOAD	UPLOAD	View HTML 0000000000-22-001311.pdf 0000000000-22-001311.rtf

Data provided by Kaleidoscope.